Newsblog

Alle Blogbeiträge

Ergebnisse filtern

Topic

03. Januar 2022

Interview Dr. Mario Iannaccone: Comparison of ECMO vs ECpella in patients with non post-pericardiotomy cardiogenic shock: An updated meta-analysis

Dr. Mario Iannaccone is interviewed on "Comparison of ECMO vs ECpella in patients with non post-pericardiotomy cardiogenic shock: An updated meta-analysis".

Based on publication of the same name in Cardiovascular Revascularization Medicine (2021)

03. Januar 2022

HFSA 2021: Clinical Evidence to Support ‘On-Pump’ Complex PCI in Heart Failure

Navin Kapur, MD, discusses clinical evidence for what he calls “on-pump” complex PCI, especially related to patients with heart failure. Dr.

08. Dezember 2021

Interview Dr. Mario Iannaccone: Short term outcomes of Impella® circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis

Dr. Mario Iannaccone is interviewed on "Short term outcomes of Impella® circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis"

22. November 2021

Interview Prof. Dr. Andreas Schäfer - Complete Revascularization in Impella Supported Infarct Related CGS Patients is Associated with Improved Mortality

Prof. Dr. Andreas Schäfer is interviewed on Complete Revascularization in Impella® Supported Infarct Related CGS Patients is Associated with Improved Mortality.

19. November 2021

Interview Dr. Mario Iannaccone - Short term outcomes of Impella® in cardiogenic shock: A review and meta-analysis of observational studies

Dr. Mario Iannaccone is interviewed on "Short term outcomes of Impella® in cardiogenic shock: A review and meta-analysis of observational studies".

Based on publication in International Journal of Cardiology (2020)

19. November 2021

Getting insight into the use of MCS in Cardiac Surgery in Germany – IMCARS registries

Prof. Böning from Gießen (Germany) presented the creation of a European MCS registry including Impella and ECLS patients.

15. November 2021

Any new solutions in structural heart disease using pMCS?

PD Schmack (Essen, Germany) explained that Impella can also give support in other indications than CS, e.g. in structural heart disease of mitral regurgitation, due to the overestimation of LV function.

15. November 2021

Combined Tx ECMO and pMCS – where is there a benefit in Cardiac Surgery?

Prof. Potapov from Berlin (Germany) highlighted the upgrade of the ESC guidelines of temporary MCS from IIb to IIa, whereas IABP is not recommended any more.

15. November 2021

Prolonged support with pMCS makeing bridge to scenarios more flexible

Dr. Bernhardt from Hamburg (Germany) demonstrated the usefulness of Impella® 5.0 and 5.5 pumps for bridge to decision making (BTD) in patients with unclear neurological prognosis.

15. November 2021

5.5. New opportunities in validation – The Impact Trial

Prof. Reichenspurner from Hamburg (Germany) presented the study design of the initial pilot trial of the IMpella Protected cArdiac surgery Trial (IMPACT).

15. November 2021

OPCAB – Surgery – does pMCS offer new perspectives - PRIME

Dr. Oezkur (Mainz, Germany) presented the PRotected off-pump coronary artery bypass grafting with IMpElla (PRIME) study series to improve outcome in OPCAB surgery.

12. November 2021

Protected PCI as a Practical Approach to MCS in Elective Complex Cases

William O'Neill, MD, diskutiert die Protected PCI als praktischen Ansatz zur mechanischen Kreislaufunterstützung bei elektiven komplexen PCI-Fällen.

12. November 2021

Improved Outcomes with Contemporary Practices in PROTECT III

Jeffrey Moses, MD, erörtert die verbesserten Ergebnisse, die in der PROTECT-III-Studie mit Impella Herzpumpen gestützten Hochrisiko-PCI-Patienten erzielt wurden.

12. November 2021

Best Practices for Treating High-Risk PCI Patients

Jason Wollmuth, MD, diskutiert Best Practises für die Behandlung von Hochrisiko-PCI-Patienten über den Large-Bore-Zugang und die intravaskuläre Bildgebung.

02. November 2021

Der kardiogener Shock – differenzierte Algorithmen mit pMCS im Spiegelbild der SCAI – Klassifikation

In seinem Vortrag erläutert Prof. Dr. Carsten Tschöpe die Klassifikation der Society for Cardiovascular Angiography & Interventions (SCAI) zur Beurteilung von Patienten im kardiogenen Schock.

NPS-891